PASITHEA THERAPEUTICS CORP. Deferred Tax Asset, Interest Carryforward
PASITHEA THERAPEUTICS CORP. (KTTA) had Deferred Tax Asset, Interest Carryforward of $8.13 million as of 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetInterestCarryforward · last filed 2025-03-24
- 2024-12-31: Deferred Tax Asset, Interest Carryforward $8.13M.
- 2023-12-31: Deferred Tax Asset, Interest Carryforward $5.15M.
- 2022-12-31: Deferred Tax Asset, Interest Carryforward $3.21M.
- 2021-12-31: Deferred Tax Asset, Interest Carryforward $920.00K.
| Period end | Deferred Tax Asset, Interest Carryforward |
|---|---|
| 2024-12-31 | $8.13M 10-K · filed 2025-03-24 |
| 2023-12-31 | $5.15M 10-K · filed 2025-03-24 |
| 2022-12-31 | $3.21M 10-K · filed 2024-03-29 |
| 2021-12-31 | $920.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |